Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


Translating preclinical MRI methods to clinical oncology.

Hormuth DA 2nd, Sorace AG, Virostko J, Abramson RG, Bhujwalla ZM, Enriquez-Navas P, Gillies R, Hazle JD, Mason RP, Quarles CC, Weis JA, Whisenant JG, Xu J, Yankeelov TE.

J Magn Reson Imaging. 2019 Mar 29. doi: 10.1002/jmri.26731. [Epub ahead of print] Review.


Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO).

Bell LC, Semmineh N, An H, Eldeniz C, Wahl R, Schmainda KM, Prah MA, Erickson BJ, Korfiatis P, Wu C, Sorace AG, Yankeelov TE, Rutledge N, Chenevert TL, Malyarenko D, Liu Y, Brenner A, Hu LS, Zhou Y, Boxerman JL, Yen YF, Kalpathy-Cramer J, Beers AL, Muzi M, Madhuranthakam AJ, Pinho M, Johnson B, Quarles CC.

Tomography. 2019 Mar;5(1):110-117. doi: 10.18383/j.tom.2018.00041.


Magnetization Transfer MRI of Breast Cancer in the Community Setting: Reproducibility and Preliminary Results in Neoadjuvant Therapy.

Virostko J, Sorace AG, Wu C, Ekrut D, Jarrett AM, Upadhyaya RM, Avery S, Patt D, Goodgame B, Yankeelov TE.

Tomography. 2019 Mar;5(1):44-52. doi: 10.18383/j.tom.2018.00019.


The effects of IKK-beta inhibition on early NF-kappa-B activation and transcription of downstream genes.

Bloom MJ, Saksena SD, Swain GP, Behar MS, Yankeelov TE, Sorace AG.

Cell Signal. 2019 Mar;55:17-25. doi: 10.1016/j.cellsig.2018.12.004. Epub 2018 Dec 10.


Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer.

Syed AK, Woodall R, Whisenant JG, Yankeelov TE, Sorace AG.

Neoplasia. 2019 Jan;21(1):17-29. doi: 10.1016/j.neo.2018.10.008. Epub 2018 Nov 23.


Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer.

Jarrett AM, Bloom MJ, Godfrey W, Syed AK, Ekrut DA, Ehrlich LI, Yankeelov TE, Sorace AG.

Math Med Biol. 2018 Sep 19. doi: 10.1093/imammb/dqy014. [Epub ahead of print]


Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.

Sorace AG, Wu C, Barnes SL, Jarrett AM, Avery S, Patt D, Goodgame B, Luci JJ, Kang H, Abramson RG, Yankeelov TE, Virostko J.

J Magn Reson Imaging. 2018 Mar 23. doi: 10.1002/jmri.26011. [Epub ahead of print]


Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.

Sorace AG, Partridge SC, Li X, Virostko J, Barnes SL, Hippe DS, Huang W, Yankeelov TE.

J Med Imaging (Bellingham). 2018 Jan;5(1):011019. doi: 10.1117/1.JMI.5.1.011019. Epub 2018 Jan 22.


Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.

Virostko J, Hainline A, Kang H, Arlinghaus LR, Abramson RG, Barnes SL, Blume JD, Avery S, Patt D, Goodgame B, Yankeelov TE, Sorace AG.

J Med Imaging (Bellingham). 2018 Jan;5(1):011011. doi: 10.1117/1.JMI.5.1.011011. Epub 2017 Nov 24.


The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.

Woodall RT, Barnes SL, Hormuth DA 2nd, Sorace AG, Quarles CC, Yankeelov TE.

Magn Reson Med. 2018 Jul;80(1):330-340. doi: 10.1002/mrm.26995. Epub 2017 Nov 8.


CCR7 Modulates the Generation of Thymic Regulatory T Cells by Altering the Composition of the Thymic Dendritic Cell Compartment.

Hu Z, Li Y, Van Nieuwenhuijze A, Selden HJ, Jarrett AM, Sorace AG, Yankeelov TE, Liston A, Ehrlich LIR.

Cell Rep. 2017 Oct 3;21(1):168-180. doi: 10.1016/j.celrep.2017.09.016.


Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.

Sorace AG, Harvey S, Syed A, Yankeelov TE.

Semin Oncol Nurs. 2017 Nov;33(4):425-439. doi: 10.1016/j.soncn.2017.08.008. Epub 2017 Sep 15. Review.


DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer.

Barnes SL, Sorace AG, Whisenant JG, McIntyre JO, Kang H, Yankeelov TE.

NMR Biomed. 2017 Nov;30(11). doi: 10.1002/nbm.3799. Epub 2017 Sep 15.


Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system.

Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, Giese N, Yu W, Nagi C, Suliburk J, Liu J, Bensussan A, DeHoog RJ, Garza KY, Ludolph B, Sorace AG, Syed A, Zahedivash A, Milner TE, Eberlin LS.

Sci Transl Med. 2017 Sep 6;9(406). pii: eaan3968. doi: 10.1126/scitranslmed.aan3968.


Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.

Sorace AG, Syed AK, Barnes SL, Quarles CC, Sanchez V, Kang H, Yankeelov TE.

Mol Imaging Biol. 2017 Feb;19(1):130-137. doi: 10.1007/s11307-016-0994-1.


Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results.

Sorace AG, Quarles CC, Whisenant JG, Hanker AB, McIntyre JO, Sanchez VM, Yankeelov TE.

Breast Cancer Res Treat. 2016 Jan;155(2):273-84. doi: 10.1007/s10549-016-3680-8. Epub 2016 Jan 20.


Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.

Barnes SL, Sorace AG, Loveless ME, Whisenant JG, Yankeelov TE.

NMR Biomed. 2015 Oct;28(10):1345-56. doi: 10.1002/nbm.3377. Epub 2015 Aug 30.


Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts.

Whisenant JG, Sorace AG, McIntyre JO, Kang H, Sánchez V, Loveless ME, Yankeelov TE.

Transl Oncol. 2014 Dec;7(6):768-79. doi: 10.1016/j.tranon.2014.09.011.


Antibody-based imaging strategies for cancer.

Warram JM, de Boer E, Sorace AG, Chung TK, Kim H, Pleijhuis RG, van Dam GM, Rosenthal EL.

Cancer Metastasis Rev. 2014 Sep;33(2-3):809-22. doi: 10.1007/s10555-014-9505-5. Review.


Biodistribution of P-selectin targeted microbubbles.

Warram JM, Sorace AG, Mahoney M, Samuel S, Harbin B, Joshi M, Martin A, Whitworth L, Hoyt K, Zinn KR.

J Drug Target. 2014 Jun;22(5):387-94. doi: 10.3109/1061186X.2013.869822. Epub 2014 Apr 14.


Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer.

Sorace AG, Korb M, Warram JM, Umphrey H, Zinn KR, Rosenthal E, Hoyt K.

Ultrasound Med Biol. 2014 Apr;40(4):755-64. doi: 10.1016/j.ultrasmedbio.2013.11.002. Epub 2014 Jan 10.


Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model.

Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K.

Ultrasound Med Biol. 2013 Dec;39(12):2374-81. doi: 10.1016/j.ultrasmedbio.2013.07.017. Epub 2013 Sep 21.


Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy.

Sorace AG, Saini R, Rosenthal E, Warram JM, Zinn KR, Hoyt K.

IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Feb;60(2):281-9. doi: 10.1109/TUFFC.2013.2564.


An animal model allowing controlled receptor expression for molecular ultrasound imaging.

Saini R, Sorace AG, Warram JM, Mahoney MJ, Zinn KR, Hoyt K.

Ultrasound Med Biol. 2013 Jan;39(1):172-80. doi: 10.1016/j.ultrasmedbio.2012.08.016. Epub 2012 Nov 2.


Ultrasound measurement of brachial artery elasticity prior to hemodialysis access placement: a pilot study.

Sorace AG, Robbin ML, Umphrey H, Abts CA, Berry JL, Lockhart ME, Allon M, Hoyt K.

J Ultrasound Med. 2012 Oct;31(10):1581-8.


Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles.

Warram JM, Sorace AG, Saini R, Borovjagin AV, Hoyt K, Zinn KR.

Cancer Gene Ther. 2012 Aug;19(8):545-52. doi: 10.1038/cgt.2012.29. Epub 2012 Jun 1.


Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer.

Sorace AG, Warram JM, Umphrey H, Hoyt K.

J Drug Target. 2012 Jan;20(1):43-54. doi: 10.3109/1061186X.2011.622397. Epub 2011 Oct 10.


A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.

Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K.

J Ultrasound Med. 2011 Jul;30(7):921-31.


Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents.

Saini R, Warram JM, Sorace AG, Umphrey H, Zinn KR, Hoyt K.

Ultrasound Med Biol. 2011 Aug;37(8):1306-13. doi: 10.1016/j.ultrasmedbio.2011.05.010. Epub 2011 Jun 16.

Supplemental Content

Loading ...
Support Center